Read More Healthcare Industry News Co-Diagnostics (Nasdaq: CODX) launches clinical trial for multiplex respiratory test as FDA approval push begins Co-Diagnostics launches trial for flu, COVID-19, RSV test kit targeting FDA clearance. Learn how it plans to lead in decentralized respiratory diagnostics. bySrinathNovember 18, 2025